20 March 2020
Health and safety of patients, our employees and their families take the highest priority for NovaMedica. As the COVID-19 situation is developing rapidly, we follow the recommendations of the federal and local authorities to prevent the infection from spreading. On March 19, NovaMedica started operating remotely.
“In addition to the measures taken to protect our employees and prevent the spread of the infection, we are actively working to ensure uninterrupted supplies of our pharmaceutical products to doctors and patients”, says Elena Litvinova, CEO of NovaMedica. “The employees of NovaMedica have all the resources necessary to continue working from home but still as a single united team”.
The company has created a working group to take action to control the virus outbreak. The group led by Deputy CEO Maria Makarova aims to organize efficient operation of the entire team of NovaMedica in the new format and to implement measures to protect the employees.
PrintGrand finale from a veritable stalwart of neuroscience
09 November 2023
Battle of pharma advocates – in search of the ideal migraine therapy
09 November 2023
31 October 2023
Long COVID study expanded across Europe
30 November 2023
Ethical, Regulatory, and Operational Considerations for Cell and Gene Therapy Research in Children
30 November 2023
Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs
29 November 2023
Imaging AI hogs the spotlight at RSNA, with debuts from GE, Siemens, Philips
29 November 2023